Best Cash-Pay Telehealths of 2026

Hims is the right cash-pay pick when the job-to-be-done is condition-specific subscription medication rather than a one-off urgent or primary-care visit. Founded 2017 in San Francisco by Andrew Dudum, Hilary Coles, Joe Spector, and Jack Abraham; NYSE:HIMS public 2021 via SPAC; revenue $1.5B in 2024 with the GLP-1 compounded program driving 70%+ year-over-year growth. The wedge is that subscription telehealth never bills insurance by design.

Hair finasteride starts at $22 monthly, ED sildenafil at $25, Mental Health at $85, and Weight Loss compounded semaglutide at $199. Cash-pay subscriptions ship from the Hims pharmacy with home delivery and no local-pharmacy prescription routing. HSA and FSA cards are eligible across every subscription tier, which matters because most cash-pay buyers fund chronic medication from tax-advantaged accounts.

The trade-off is that subscription telehealth covers ongoing condition-specific medication, not urgent care, primary care, or longitudinal therapy follow-up. The mental-health line provides brief medication-management visits, not the multi-session therapy depth Doctor On Demand or Teladoc offer. Hims fits the buyer who wants medication delivered monthly without ever filing an insurance claim.

Ro is the right cash-pay pick when the budget calls for the cheapest single-condition subscription in the catalog. Founded 2017 as Roman by Zachariah Reitano, Saman Rahmanian, and Rob Schutz; rebranded to Ro in 2019; private, $876M total funding through 2022 Series E at a $7B valuation. The wedge is the entry price: Roman ED at $17 monthly is the cheapest credible single-condition cash subscription available, undercutting Hims ED by $8 monthly.

Hair Loss runs $24 monthly. Body GLP-1 at $145 monthly includes active insurance-navigation support for the brand-name Wegovy and Ozempic path, which matters because brand-name GLP-1 with insurance approval costs the cash buyer dramatically less than the $1,000-plus retail price. Compounded semaglutide is the fallback when insurance does not approve.

The trade-off is the narrower product mix. No mental-health line and fewer add-on conditions than Hims means Ro is rarely the all-in-one men's pick. Ro fits the buyer who specifically wants the cheapest single-condition entry price or brand-name GLP-1 with insurance navigation. Default to Hims when the buyer wants broader subscription mix.

Sesame Care is the right pick for any cash-pay buyer who wants to know the visit cost before clicking book. Founded 2018 in New York by David Goldhill and Michael Botta; $90M total funding through 2022 Series B led by GV. The wedge is the marketplace model: providers list cash rates directly, you book on those rates, and no insurance claim ever fires. Walk-in video visits land at $30, the cheapest credible cash visit in the lineup.

In-person primary-care visits at $60 connect you with a local doctor through the same booking flow when video is not enough. Therapy sessions at $65 are also among the cheapest cash mental-health options. HSA and FSA cards are accepted across every visit type, which matters when the cash-pay buyer is funding visits from a tax-advantaged account.

The trade-off is the absence of insurance billing. No claims to submit later, no in-network rate to fall back on, no copay surprise. This is a feature when you are uninsured and a tax decision when you are HDHP-eligible. Sesame fits the uninsured visitor, the privacy-conscious visitor, and the buyer who simply wants the visit cost posted before they commit.

Teladoc is the right cash-pay pick when brand recognition and the URAC plus NCQA plus Joint Commission accreditation triple matter more than the cheapest cash visit price. Founded Dallas 2002 by G. Byron Brooks MD and Michael Gorton; NYSE:TDOC public 2015; the largest virtual-care company by revenue at $2.6B in 2023. The wedge is that no other pick in the cash subset ships all three accreditations.

Cash medical visits run $89, therapy $99 per session, psychiatry $299 initial with $129 follow-ups. Available in all 50 states plus DC and Puerto Rico, 24/7 urgent care, with 80 million-plus members through employer and insurance partnerships. The Livongo acquisition in 2020 for $18.5B added the chronic-condition pivot.

The trade-off is the price gap. Teladoc cash sits at $89 when Sesame walk-in lands at $30 and Doctor On Demand cash at $75, both URAC-accredited at the lower end. Teladoc fits the cash buyer who wants the most-recognized brand or the broader accreditation triple; Sesame and Doctor On Demand fit the buyer optimizing for visit price.

Doctor On Demand is the right cash-pay pick for buyers who want the same accreditation enterprise plans rely on at the cheapest cash visit price among the three URAC-accredited incumbents. Founded 2012 in San Francisco by Adam Jackson and Phil Marshall; merged with Grand Rounds in 2021 to form Included Health (Permira and Carlyle backed at a $13B valuation). The wedge is the $14 gap below Teladoc and Amwell at the cash-medical tier with the same URAC-accredited provider network.

Medical visits run $75 cash, the cheapest urgent-care visit among URAC-accredited enterprise incumbents. Therapy at $129 per session ships continuity-of-care guarantees with the same therapist across sessions. Psychiatry runs $299 initial with $129 follow-ups. Available in all 50 states with 24/7 urgent care, the cash buyer gets the same coverage an enterprise-sponsored buyer gets.

The trade-off is that $75 still sits well above the $30 Sesame walk-in. Doctor On Demand is the right cash pick when the buyer wants URAC accreditation as a quality floor; Sesame fits when cheapest visit price is the only constraint. No primary care, no GLP-1 program, and a smaller mental-health network than Teladoc.